Cipla Fact Sheet, Cipla Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cipla Fact Sheet    (CIPL)


Get Details: We are Bullish on These 3 Little-known Stocks


Here is the latest financial fact sheet of Cipla. For more details, see the Cipla quarterly results and Cipla share price and chart. For a sector overview, read our pharmaceuticals sector report.

CIPLA Price History

Price Rs 884.2
Mkt Cap Rs m 712,693
Vol '000 235.3
P/E X 32.0
P/CF X 26.2
EPS (TTM) Rs 27.6
% ch % 0.4
No. of shares m 806.08
% ch week % -1.8
% ch 1-mth % -6.6
% ch 12-mth % 47.2
52 week H/L Rs 966.0/570.5
(As on May 18, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

CIPLA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
CIPLA EQUITY SHARE DATA
High Rs748622663678586 
Low Rs495458479484357 
Sales per share (Unadj.) Rs171.7181.9183.2198.2207.0 
Earnings per share (Unadj.) Rs17.212.917.618.518.6 
Diluted earnings per shareRs17.212.817.618.518.6 
Cash flow per share (Unadj.) Rs26.629.334.035.033.2 
Dividends per share (Unadj.) Rs2.002.003.003.004.00 
Adj. dividends per shareRs1.992.003.003.004.00 
Dividend yield (eoy) %0.30.40.50.50.8 
Book value per share (Unadj.) Rs143.3155.9176.7186.3195.5 
Adj. book value per shareRs142.9155.6176.5186.2195.6 
Shares outstanding (eoy) m803.38804.51805.12805.70806.35 
Bonus / Rights / Conversions  ESOPESOPESOPESOPESOS 
Price / Sales ratio x3.63.03.12.92.3 
Avg P/E ratio x36.142.032.531.425.3 
P/CF ratio (eoy) x23.418.416.816.614.2 
Price / Book Value ratio x4.33.53.23.12.4 
Dividend payout %11.615.517.116.221.5 
Avg Mkt Cap Rs m499,381434,516459,724468,031379,912 
No. of employees `00024.123.023.622.625.8 
Total wages/salary Rs m24,34026,33826,90128,56530,270 
Avg. sales/employee Rs Th5,723.76,349.16,247.77,053.16,459.6 
Avg. wages/employee Rs Th1,010.31,143.01,139.41,261.51,171.2 
Avg. net profit/employee Rs Th574.2449.3600.0659.1580.2 
CIPLA INCOME DATA
Net Sales Rs m137,901146,302147,509159,710166,949 
Other income Rs m2,0822,2873,5774,7663,442 
Total revenues Rs m139,983148,589151,085164,475170,391 
Gross profit Rs m24,79724,75828,26430,97332,060 
Depreciation Rs m7,54213,22913,22813,26311,747 
Interest Rs m2,0661,5941,1421,6841,974 
Profit before tax Rs m17,27012,22217,47020,79121,782 
Minority Interest Rs m00-28-172-475 
Prior Period Items Rs m-120-70000 
Extraordinary Inc (Exp) Rs m00-77500 
Tax Rs m3,3161,7982,5015,6956,312 
Profit after tax Rs m13,83410,35414,16614,92414,995 
Gross profit margin %18.016.919.219.419.2 
Effective tax rate %19.214.714.327.429.0 
Net profit margin %10.07.19.69.39.0 
CIPLA BALANCE SHEET DATA
Current assets Rs m88,41287,356108,141124,266117,038 
Current liabilities Rs m77,76133,73738,32237,71543,931 
Net working cap to sales %7.736.647.354.243.8 
Current ratio x1.12.62.83.32.7 
Inventory Days Days101871009196 
Debtors Days Days6264779585 
Net fixed assets Rs m110,786111,567109,411105,190107,424 
Share capital Rs m1,6071,6091,6101,6111,613 
"Free" reserves Rs m113,555123,828140,682148,511156,018 
Net worth Rs m115,162125,437142,292150,123157,630 
Long term debt Rs m2,21936,45436,62138,30123,693 
Total assets Rs m211,282210,371228,606239,633236,626 
Interest coverage x9.48.716.313.312.0 
Debt to equity ratio x00.30.30.30.2 
Sales to assets ratio x0.70.70.60.70.7 
Return on assets %7.55.76.76.97.2 
Return on equity %12.08.310.09.99.5 
Return on capital %16.48.510.011.812.8 
Exports to sales %48.534.233.834.733.0 
Imports to sales %12.58.3000 
Exports (fob) Rs m66,83750,05049,88355,41955,175 
Imports (cif) Rs m17,27012,203000 
Fx inflow Rs m67,46151,06651,69157,41056,036 
Fx outflow Rs m24,72917,67821,03319,0416,764 
Net fx Rs m42,73333,38830,65838,36849,272 
CIPLA CASH FLOW
From Operations Rs m 17,408 23,818 14,628 16,911 30,685 
From Investments Rs m -45,226 -13,102 -8,540 -16,687 1,040 
From Financial Activity Rs m 31,041 -13,257 -3,855 -3,487 -29,488 
Net Cashflow Rs m 3,123 -2,478 2,431 -3,451 2,340 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 16.0%
Foreign collaborators 20.8%
Indian inst/Mut Fund 12.2%
FIIs 23.7%
ADR/GDR 1.1%
Free float 26.2%
Shareholders 161,166
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-13
E-MAIL cosecretary@cipla.com WEB www.cipla.com
TELEPHONE (022) 2482 6000 FAX (022) 2482 6893
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR V. Sankar Aiyar & Co.
CHM: Y. K. Hamied (MD) COMP SEC: Mital Sanghvi YEAR OF INC: 1935 BSE CODE: 500087 FV (Rs): 2 DIV YIELD (%): 0.5

Read: CIPLA 2019-20 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   ASTRAZENECA PHARMA  ALEMBIC  SUN PHARMA  DIVIS LABORATORIES  ALEMBIC PHARMA  

Compare CIPLA With:   ASTRAZENECA PHARMA  ALEMBIC  SUN PHARMA  DIVIS LABORATORIES  ALEMBIC PHARMA  

Compare CIPLA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  




Today's Market

5 Reasons Why Sensex Zoomed 613 Points Today(Closing)

Indian share markets extended gains as the session progressed and ended on a strong note.

Views on news

Cipla's Q4 Update: Net Profit Surges 68%; Company to Pay Rs 5 Dividend (Views On News)

May 17, 2021

Here's a rundown on the latest quarterly results of Cipla.

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2019-20 Annual Report Analysis (Annual Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

Here's an analysis of the annual report of CIPLA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Gland Pharma Q4 results: Net profit rises 34%; Share Price Hits New 52-Week High (Views On News)

May 18, 2021

The new vaccine business is expected to accelerate the company's long-term strategy of entering into the biosimilar space.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK CIPLA

MORE ON CIPLA

CIPLA - ACTAVIS COMPARISON

COMPARE CIPLA WITH

MARKET STATS